Search results
ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success
Clinical Trials Arena via Yahoo Finance· 20 hours agoVerastem gained an exclusive wordwide licence for avutometinib from Chugai Pharmaceuticals in...
Here's how U.S. health officials are responding to bird flu in humans after second case
CNBC· 17 hours agoU.S. health officials are monitoring and preparing to combat bird flu in humans, even as they...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 21 hours agoWhile these three stocks gained notoriety back in 2020 during the COVID-19 pandemic, it appears this week's detection of avian bird flu in a second...of...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 2 days agoThis month, the company announced it was pulling the vaccine off the market globally, citing a decline in demand. The association between the AstraZeneca COVID-19 vaccine and a rare and dangerous ...
AstraZeneca sets sights on $80B in revenue by 2030
BioPharma Dive via Yahoo Finance· 4 days agoWelford forecasts more than $9 billion in peak sales for datopotamab deruxtecan, which is part of a partnership with Daiichi Sankyo. Executives are...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 5 days agoModerna CEO Stéphane Bancel recently told Barron’s that launching the shots in August instead of...
Arizona researcher publishes study on COVID-19 vaccine and tinnitus
ABC 15 Phoenix· 3 hours agoShaowen Bao, a University of Arizona professor, and Robert Edmonds, a COVID-19 vaccine patient from New Mexico. “It’s very difficult when you have a very sudden event, and you're trying to get ...
Vaccine makers receive stock boost after third human bird flu case in US
Newsweek· 2 days agoShares in some companies that produce vaccines have seen stock boosts following a small number of...
Why This Biotech Just Launched — Again — After Its 166% Run
Investor's Business Daily· 5 days agoDyne studied drugs it calls DYNE-101 and DYNE-251 in patients with myotonic dystrophy type 1 and...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli...
Zacks via Yahoo Finance· 5 days agoAfter all, Moderna was not the behemoth it is today. Until 2020-end, the company lacked a marketed...